Glatiramer acetate and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Glatiramer acetate (glatiramer acetate), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Ampyra, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Insomnia when taking Glatiramer acetate. It is created by eHealthMe based on reports of 5,153 people who have side effects when taking Glatiramer acetate from the FDA, and is updated regularly.

What is Glatiramer acetate?

Glatiramer acetate has active ingredients of glatiramer acetate. eHealthMe is studying from 5,158 Glatiramer acetate users. Check the latest studies of Glatiramer acetate.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,169 conditions by eHealthMe. Check the latest studies of Insomnia.

On Jul, 13, 2026

5,153 people reported to have side effects when taking Glatiramer acetate.
Among them, 51 people (0.99%) have Insomnia.

Could Glatiramer acetate cause Insomnia?

Among these 51 people:

How long have people been on Glatiramer acetate when they have Insomnia? *

What is the gender of people who have Insomnia when taking Glatiramer acetate? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Insomnia when taking Glatiramer acetate? *

What are other drugs people take besides Glatiramer acetate? *

What are other side effects people have besides Insomnia? *

Injection Site Pain: 15 people, 29.41%
Headache (pain in head): 14 people, 27.45%
Injection Site Bruising: 11 people, 21.57%
Hypoaesthesia (reduced sense of touch or sensation): 10 people, 19.61%
Pain In Extremity: 8 people, 15.69%
Fall: 8 people, 15.69%
Stress And Anxiety: 8 people, 15.69%
Dizziness: 7 people, 13.73%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 13.73%
Drug Ineffective: 7 people, 13.73%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 26 people, 50.98%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 17 people, 33.33%
Gait Disturbance: 4 people, 7.84%
Weakness: 2 people, 3.92%
Respiratory Tract Infection: 2 people, 3.92%
Cardiac Disorder: 2 people, 3.92%
Stress And Anxiety: 1 person, 1.96%
Scoliosis (a medical condition in which a person's spine is curved from side to side): 1 person, 1.96%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 1.96%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Glatiramer acetate and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glatiramer acetate:

Glatiramer acetate (5,158 reports)

Insomnia treatments and more:

Insomnia (438,078 reports)

Browse all side effects of Glatiramer acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,118 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,169 conditions)

Related publications that referenced our studies

Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Glatiramer acetate) and Glatiramer acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.